Poly Medicure Limited announced its unaudited financial results for the third quarter and nine months ended December 31, 2025. The company reported consolidated revenue from operations of ₹11,281.88 crore for the quarter, a significant increase compared to previous periods. Net profit after tax for the quarter stood at ₹7,838.38 crore. The company also reported standalone results for the same period. The Board of Directors, in their meeting held on February 5, 2026, approved these financial results. Additionally, the Nomination & Remuneration Committee approved the grant of 2,000 stock options under the Poly Medicure Limited Employee Stock Option Scheme 2020 to eligible employees. The meeting commenced at 12:45 PM and concluded at 02:35 PM. The financial results detailed include a provision of ₹680.40 lakh for past service cost related to gratuity and compensated absences due to the implementation of new Labour Codes, classified as exceptional items.
